April 22, 2015

Five macro trends impacted sales of OTC medicines in 2014, Bob Sanders, EVP at IRI, shared with attendees of the Consumer Healthcare Products Association Annual Executive Conference in March. On the plus side, switch continues to drive considerable growth across OTC aisles — Rx-to-OTC accounted for 1970 of OTC sales and 2770 of growth in the past five years, and that trend is likely to continue, Sanders said

April 22, 2015

If you were impressed by the recent switches of Nasacort Allergy 24HR, Nexium 24HR or Flonase — well-executed and model switches — well, you ain’t seen nothing yet.

April 2, 2015

A Kline industry expert pointed to the launch of Nasacort 24HR as a significant driver behind the 10% increase in allergy sales. 

March 18, 2015

Chattem on Wednesday teamed with a pair of allergy experts on the importance of smell to allergy sufferers. 

March 4, 2015

According to ECRM’s analysis of circular retail promotions for allergy, Chattem emerged as the leading advertiser of allergy remedies.

March 4, 2015

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.

March 4, 2015

Chattem’s launch of the first nasal corticosteroid onto OTC shelves represented the most significant success story in the cough-cold-allergy space in the past year. 

February 5, 2015

The Centers for Disease Control and Prevention acknowledged early on in the 2014-15 season that this year’s flu shot didn’t match up well with this year’s predominant H3N2 flu virus, which set the stage for a strong season. Annual sales of cough, cold and flu remedies were on the rise for the first two months of the season.

August 6, 2014

The National Advertising Division on Wednesday determined that Chattem can support certain advertising claims for “Nasacort Allergy 24HR,” an over-the-counter allergy relief medication. The claims were challenged by Merck Consumer Care.

June 18, 2014

There’s a lot happening in the allergy space right now. Chattem’s Nasacort Allergy 24HR recently hit store shelves, and in a little more than 10 weeks on the shelf the nasal corticosteroid has already generated $33.6 million in sales across total U.S. multi-outlets, according to IRI.

May 27, 2014

The May/June 2014 Skin & Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Cerapeutic Restoring, Cetaphil RestoraDerm Skin Restoring, Olay Advanced Healing Intensive, Curél Intesive Healing, Nivea Extended Moisture, Aveeno 1% Hydrocortisone Anti-itch, Extra Strength Benadryl Itch Stopping and Corizone 10 Anti-itch Ultra Moisturing Creme Plus.

April 21, 2014

DSN highlights the best practices in in-store merchandising and marketing in the OTC category.

March 26, 2014

The March/April 2014 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Children's Claritin Chewable, Children's Allegra Allergy meltable tablets, Children's Benadryl Allergy Liquid, Nasacort Allergy 24HR, Mucinex Allergy, Hyland's 4 Kids Complete Allergy and Similasan Kids Allergy Eye Relief.

March 10, 2014

Two Rx-to-OTC switches in the past year may serve as a harbinger of what the Food and Drug Administration will consider “switch” worthy.

February 18, 2014

Retailers were preparing for the imminent launch of Chattem’s Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) last month, clearing out quite a bit of shelf space for the new allergy remedy.

February 4, 2014

Sanofi and its U.S. consumer healthcare division Chattem on Tuesday announced that Nasacort Allergy 24HR Nasal Spray is now available over the counter in the United States to relieve seasonal and year-round nasal allergy symptoms, including nasal congestion, in adults and children 2 years of age and older.

October 18, 2013

Chattem recently announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies. And that means by spring 2014, there will be another allergy powerhouse alongside Allegra, Claritin and Zyrtec.

October 14, 2013

Allergy sufferers will have a new treatment option available to them by the spring allergy season. Sanofi on Friday announced that the Food and Drug Administration approved Nasacort Allergy 24HR nasal spray (triamcinolone intranasal) as an over-the-counter treatment for seasonal and year-round nasal allergies in adults and children 2 years of age and older.